Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease-Reference-Cited by-同舟云学术

Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease

Published:2020-06-08 Issue:4 Volume:23 Page:689-695
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Sarkar Reith R.,Patel Sunil H.,Parsons J. Kellogg,Deka Rishi,Kumar Abhishek,Einck John P.,Mundt Arno J.,Kader A. Karim,Kane Christopher J.,Riviere Paul^ORCID,McKay Rana,Murphy James D.,Rose Brent S.^ORCID

Funder

U.S. Department of Health and Human Services

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-020-0241-3.pdf

Reference25 articles.

1. Araujo AB, Esche GR, Kupelian V, O’Donnell AB, Travison TG, Williams RE, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92:4241–7. https://doi.org/10.1210/jc.2007-1245.

2. Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–35. https://doi.org/10.1056/NEJMoa0911101.

3. Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, et al. Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol. 2016;174:R99–116.

4. Hackett G. An update on the role of testosterone replacement therapy in the management of hypogonadism. Ther Adv Urol. 2016;8:147–60. https://doi.org/10.1177/1756287215617648.

5. Fowler JEJ, Whitmore WFJ. The response of metastatic adenocarcinoma of the prostate to exogenous testosterone. J Urol. 1981;126:372–5. https://doi.org/10.1016/s0022-5347(17)54531-0.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone Therapy and Prostate Cancer;Urologic Clinics of North America;2022-11

2. The Role of Post-Radical Prostatectomy Testosterone Therapy in Erectile Function Recovery;Androgens: Clinical Research and Therapeutics;2022-10-01

3. Safety of androgen therapy in men with prostate cancer;Best Practice & Research Clinical Endocrinology & Metabolism;2022-09

4. The Relationship Between PSA and Total Testosterone Levels in Men with Prostate Cancer;The Journal of Sexual Medicine;2022-02-09

5. Updated Review of Testosterone Replacement Therapy in the Setting of Prostate Cancer;Androgens: Clinical Research and Therapeutics;2021-01-01